The liver is an important target organ of thyroid hormone. However, only a limited number of hepatic target genes have been identified, and little is known about the pattern of their regulation by thyroid hormone. We used a quantitative fluorescent cDNA microarray to identify novel hepatic genes regulated by thyroid hormone. Fluorescent-labeled cDNA prepared from hepatic RNA of T 3 -treated and hypothyroid mice was hybridized to a cDNA microarray, representing 2225 different mouse genes, followed by computer analysis to compare relative changes in gene expression. Fifty five genes, 45 not previously known to be thyroid hormone-responsive genes, were found to be regulated by thyroid hormone. Among them, 14 were positively regulated by thyroid hormone, and unexpectedly, 41 were negatively regulated. The expression of 8 of these genes was confirmed by Northern blot analyses. Thyroid hormone affected gene expression for a diverse range of cellular pathways and functions, including gluconeogenesis, lipogenesis, insulin signaling, adenylate cyclase signaling, cell proliferation, and apoptosis. This is the first application of the microarray technique to study hormonal regulation of gene expression in vivo and should prove to be a powerful tool for future studies of hormone and drug action. (Molecular Endocrinology 14: 947-955, 2000)
INTRODUCTION
Thyroid hormones (T 3 and T 4 ) have profound effects on metabolism, growth, and development (1) . The effects of thyroid hormone are mediated by thyroid hormone receptors (TRs) that belong to the nuclear hormone receptor superfamily; these include the steroid hormone receptors, the retinoic acid receptors, the retinoid X receptors , the vitamin D receptor, the peroxisome proliferator-activated receptors, and other orphan receptors (2, 3) . TRs are encoded by two genes (␣ and ␤) and are expressed as several isoforms (TR␣, TR␤1, and TR␤2) (2, 3) . TRs bind to thyroid hormone-response elements in the promoters of target genes. Interestingly, T 3 can positively and negatively regulate transcription of target genes (2-4); however, only a few of the approximately 30 known target genes are negatively regulated. Moreover, most of these negatively regulated target genes are expressed in the pituitary or hypothalamus (2-4) rather than peripheral tissues.
The liver is a major target organ of thyroid hormone. It has been estimated that approximately 8% of the hepatic genes are regulated by thyroid hormone in vivo (1) , and thus the liver is an ideal tissue to study gene regulation by thyroid hormone. Although a limited number of individual target genes in the liver have been studied, a large-scale profile of the target genes regulated by thyroid hormone has not been undertaken. cDNA microarray hybridization is a powerful tool to study hormone effects on cellular metabolism and gene regulation on a genomic scale as it enables simultaneous measurement and comparison of the expression levels of thousands of genes (5, 6) . Recently, cDNA microarrays have been used to study the gene expression due to fibroblast differentiation; oncogenesis; aging and caloric restriction of mouse muscle; cell cycle in yeast; and differentiation in Drosophila (7) (8) (9) (10) (11) (12) (13) . They also have been used in drug development programs to monitor changes in gene expression due to drug treatment (14) . Additionally, two groups recently have used microarrays to examine broad patterns of gene regulation in leukemias and lymphomas and correlate the pattern with clinical outcome (15, 16) . Thus far, microarrays have not been used to assess hormonal regulation of target genes and their patterns of expression.
We have used a cDNA microarray to study the hepatic gene expression in hypothyroid mice treated with T 3 . We have identified 55 target genes, with 14 upregulated and 41 down-regulated by T 3 . Most of these genes have not previously been described to be regulated by thyroid hormone. Analyses of their expression profile revealed thyroid hormone effects on multiple cellular pathways. This study also is the first application of cDNA microarray technology to study hormonal regulation of target genes in vivo.
RESULTS AND DISCUSSION

Microarray Analyses
To investigate the effect of thyroid hormone on hepatic gene expression, RNA from hypothyroid and T 3 -treated mice was prepared, labeled with fluorescent dye, and hybridized with the cDNA microarray as described in Materials and Methods. The color images of the hybridization results ( Fig. 1) were made by representing the Cy3 fluorescent image as green and Cy5 fluorescent image as red, and merging the two color images. Similar findings were observed in a total of six independent microarray studies of livers from individual mice treated with T 3 or T 4 .
We sampled 2225 genes on the cDNA microarray, which represents approximately 10% of the expressed genes in liver, assuming that the liver transcriptosome contains 10,000-20,000 genes (20) . We found that 14 genes (0.6%) displayed a greater than 2-fold increase in expression levels after thyroid hormone treatment whereas 41 genes (2.4%) displayed more than a 60% decrease in gene expression (Table 1 ). This latter finding was surprising since there are only a few known negatively regulated target genes in peripheral tissues. Seven of 14 of the positively regulated genes were not identified previously as thyroid hormone-responsive, whereas 38/41 of the negatively regulated genes were not identified previously as such. Three genes (malic enzyme, ␣ myosin heavy chain, and myelin basic protein) have been described previously to be regulated by T 3 but did not show significant induction in our studies even though they were contained on the microarray. The latter two genes are predominantly expressed in heart and brain, respectively, and not significantly expressed in liver (19) . Weiss et al. (17) recently treated a different strain of mice for 4 days with T 3 and observed induction of malic enzyme mRNA (17) . The observed lack of T 3 -induction of malic enzyme mRNA may be due to delayed time course of induction (6 h vs. 4 days) or differences in mouse strains.
The changes in mRNA levels of several known and novel target genes on the microarray were confirmed by Northern blot analysis (Fig. 2) . Our data are consistent with previous studies that have shown that cDNA microarrays can predict induction and repression of gene expression on Northern blots with high reliability (7, 10) . The major factors affecting the reliability of microarray analyses are the quality of RNA and the efficiency of labeling. Therefore, hybridization and microarray analyses were only performed in samples in which high specific labeling of RNA was achieved. Only genes that were regulated in three separate experiments comparing mice treated with propylthiouracil (PTU) Ϯ T 3 are included in Table 1 . These results also were confirmed in three additional experiments in which mice were treated with PTU Ϯ T 4 .
Consistent with some of the known metabolic effects of thyroid hormone, T 3 regulated a diverse range of genes that affect many different aspects of cellular metabolism and function such as gluconeogenesis, lipogenesis, insulin signaling, adenylate cyclase sig- A microarray was hybridized to total RNA from hypothyroid mouse liver (green fluorochrome) and hyperthyroid mouse liver after 6 h treatment with thyroid hormone (red fluorochrome). RNA from the hypothyroid mouse liver was used to prepare cDNA labeled with Cy3-deoxyuridine triphosphate (dUTP), and mRNA hyperthyroid mouse liver was used to prepare cDNA labeled with Cy5-dUTP. The two cDNA probes were mixed and then simultaneously hybridized to the microarray. In this image of the subsequent scan, mRNAs that were more abundant in hypothyroid mouse liver (suppressed by thyroid hormone) were detected as green spots, whereas mRNAs that were more abundant in hyperthyroid mouse liver (stimulated by thyroid hormone) were detected as red spots. Yellow spots represented genes whose expression did not vary substantially between the two samples.
The arrows indicate spots representing the following genes: 1. Bcl-3; 2. carbonyl reductase; 3. B61; 4. membrane-type matrix metalloproteinase; 5. Spot 14. This table was generated from a comparison of RNA from a single hypothyroid mouse and a single T 3 -treated mouse. Similar results were observed in six independent studies of individual mice treated with T 3 or T 4 . Genes printed in italics are positively regulated whereas genes printed in normal print are negatively regulated.
naling, cell proliferation, and apoptosis (Table 1 and Fig. 3 ).
Gene Profiles and Novel Target Genes Regulated by T 3
T 3 stimulates gluconeogenesis and glucose production in the liver and thus opposes the action of insulin with respect to hepatic glucose production (21, 22) . It also is known that hyperthyroidism worsens glycemic control in diabetic patients (23, 24) . In accord with these findings, we found an increase in glucose-6-phosphatase mRNA expression, the key enzyme for conversion of glucose-6-phosphate to glucose. Additionally, we observed a decrease in mRNA expression of a critical downstream component of the insulinsignaling pathway, Akt2 (protein kinase B). Akt2 is a serine/threonine kinase that is activated by insulin and other growth factors via phosphatidylinositol 3 kinase (25, 26) . Akt2 has been shown to stimulate glucose uptake in peripheral tissues via GLUT 4 glucose transporter and to promote glycogen synthesis in liver by inactivating glycogen synthase kinase 3 (27) (28) (29) . Thus, a decrease in Akt2 activity would decrease glycogen synthesis. It also is interesting that T 3 decreased capping protein ␣ subunit and ␣ adaptin mRNA which encode proteins that are involved in the redistribution and internalization of the liganded insulin receptor (30, 31) . In this connection, it recently was reported that there is decreased endocytosis of insulin receptors in hepatocytes of diabetic rats (32) . T 3 also increased insulin-like growth factor (IGF) binding protein-1 mRNA, which inhibits IGF-I signaling as reported previously (33) . It previously has been shown that thyroid hormone can mimic or enhance the glycogenolytic and gluconeogenic effects of epinephrine and glucagon in hepatocytes, and increase intracellular cAMP (21, (34) (35) (36) . Consistent with these findings, we observed induction of ␤2-adrenergic receptor mRNA and repression of inhibitory G protein (Gi) mRNA of the adenylate cyclase cascade (Table 1) . Thus, T 3 has complementary effects on two opposing pathways that regulate intracellular cAMP. Additionally, T 3 may have other effects on this signaling cascade as T 3 has been reported to redistribute Gs␣ from cytosol to the plasma membrane, up-regulate Gs␣, and down-regulate Gi␣ expression in the plasma membrane, as well as modulate the activity of phosphodiesterase (37, 38) .
Hepatic lipogenesis is regulated by dietary substrates and hormones such as insulin and thyroid hormone, which control fuel metabolism and biosynthesis (1). We observed increased mRNA expression of spot 14 (S14), a key protein that regulates lipogenesis that previously was shown to be induced by T 3 (39) . We also saw induction of fatty acid transport protein mRNA, which encodes a plasma membrane protein that is highly expressed in liver that mediates the transport of long chain fatty acids into cells (40) . We did not observe induction of malic enzyme mRNA, which is known to be stimulated by T 3 (17, 39, 41) . It is possible that malic enzyme may have a delayed response to T 3 or may be regulated by Spot 14 (39, 42) . Recently, it has been reported that T 3 also can downregulate cytochrome p450 4A3 (Cyp4A3) mRNA (43) and that Cyp4A10 mRNA is increased in diabetic rats (44) . We observed that T 3 decreases mitochondrial acyltransferase Cyp4A10 mRNAs, which, in turn, could reduce fatty acid oxidation acutely and increase lipogenesis.
T 3 also decreased another downstream insulin signaling component, PHAS (phosphorylated heat-and acid-stable protein), which is the 4E(eIF-4E)-binding protein that complexes with the eukaryotic initiation factor, eIF4E, and inhibits eIF-4E-dependent translation. Phosphorylation of PHAS by insulin signaling causes dissociation of PHAS from the PHAS-eIF-4E complex, and leads to increased translation (45, 46) . Since T 3 down-regulated PHAS, it is possible that T 3 , a known hepatic mitogen, may have an insulinmimetic effect with respect to protein synthesis. On the other hand, T 3 decreases Akt2 mRNA expression and increases intracellular cAMP, which may decrease phosphorylation of PHAS (46, 47) and thus inhibit translation. Despite studies of thyroid hormone regulation of protein synthesis (48, 49) , neither the detailed mechanism nor the net effects of T 3 on translation are known.
Previous reports have shown that T 3 has complex effects on hepatocyte proliferation and cell survival (50) (51) (52) . Consistent with these effects, we observed changes in genes involved in apoptosis and cell cycle progression. In particular, genes involved in cell proliferation such as Bcl3, B61, and kinesin-like protein (Kip1p) were induced by T 3 . Bcl3 is an IB-related protein that behaves differently than IB as it can act as a coactivator for nuclear factor (NF)B homodimers (53) (54) (55) . It also functions as a coactivator for AP-1 complexes and retinoid X receptors (56) and thus potentially may serve as a coactivator for TR itself. B61 is a glycosylphosphatidylinositol-linked protein, which serves as a ligand for Eck receptor protein-tyrosine kinase (57) and may act as a hepatic mitogen. Kip1p participates in the segregation of chromosomes during mitosis by modulating the movement of spindle assembly and chromosome distribution (58) . Recent studies suggest that T 3 stimulation of proliferation may be of clinical importance in gene therapy as it may promote the transfection of viral vectors into liver (59, 60) .
Although T 3 stimulates hepatocyte proliferation, it also can stimulate apoptosis in hepatocytes in which proliferation is pharmacologically blocked, and in amphibian tails during metamorphoses (52, 61) . In this connection, we found that several genes involved in apoptosis were regulated by T 3 , as T 3 decreased expression of Akt2 and protein kinase C (PKC) mRNA, and increased expression of the PKC inhibitor, (PKCi) mRNA. Akt2 can induce phosphorylation of caspase-9 to inhibit its protease activity, as well as activate NFB (62) . PKC, an atypical form of PKC, has been shown to be critically involved in important cell functions such as proliferation and cell survival. PKC activates IB kinase B, which then can activate NFB (63) . Additionally, PKCi opposes the action of PKC, so induction of PKCi would promote apoptosis (64) .
In our microarray studies, T 3 negatively regulated several genes involved in glycoprotein synthesis such as ␤-galactoside ␣ 2,6-sialyltransferase, and ␣-2,3-sialyltransferase. Of note, hypothyroidism has been shown to induce ␣-2,3-sialyltransferase expression in pituitary thyrotrophs (65) . The sialyltransferases catalyze the transfer of sialic acid from cytidine 5Ј-monophospho-N-acetylneuraminic acid (CMP-NeuAc) to terminal positions on sugar chains of glycoproteins and glycolipids (66) and are markers for many tumors (67, 68) . Finally, T 3 negatively regulated genes involved in cellular immunity, cell matrix, cell structure, endocytosis, and mitochondrial function which, in turn, may represent novel areas of T 3 action (Table 1) .
To confirm and extend our findings on newly discovered target genes, we performed a separate time course experiment on T 3 regulation of two newly identified target genes, Bcl-3 and ␣ 2,3 sialyltransferase. mRNA was measured by Northern blot analyses from livers harvested from mice at various times after T 3 treatment. Bcl-3 mRNA levels were induced approximately 10-fold 1 h after T 3 treatment and declined to 5-fold by 3 h (Fig. 4A) . ␣-2,3-Sialyltransferase mRNA levels decreased 1 h after T 3 treatment and reached their nadir at 3 h. (Fig. 4B) . It is possible that ␣-2,3 sialyltransferase and some of the other negatively reg-ulated target genes identified by our microarray may serve as new markers of thyroid hormone action outside the pituitary, as well as tools for understanding the mechanism of negative regulation by nuclear hormone receptors.
Although the majority of the cells within the liver are hepatocytes, it is possible that regulated genes from other cell types (e.g. endothelial cells, Kupfer cells, red blood cells) may also have been detected by the microarray. Furthermore, although we studied gene expression relatively soon after T 3 administration (6 h), it is not known whether all the target genes identified are regulated directly by T 3 . It is possible that intracellular factors may be rapidly induced which, in turn, may regulate some of the target genes we have described. Also, since this study was performed in vivo, it is possible that hormones that are regulated by T 3 may regulate some of the target genes. In particular, GH is induced by T 3 in rodents and was found to coregulate a small subset of T 3 -induced target genes that were studied by Oppenheimer and associates (69) using two-dimensional protein gel electrophoresis (69) . Microarray studies using hypophysectomized mice, GH receptor knockout mice, or GH antagonists may help clarify this issue. Despite these potential limitations, our study has demonstrated the utility of cDNA microarrays to identify novel target genes in vivo and extend the applicability of this powerful technology beyond conventional cell culture systems.
In conclusion, we have used cDNA microarray technology to analyze gene expression changes in mouse liver after administration of thyroid hormone. We identified 55 target genes, most of which have not been described previously. Surprisingly, many of these target genes were negatively regulated. Two recent reports have demonstrated the broad patterns of gene expression that can occur in human disease (15, 16) . Similarly, we have observed changes in the patterns of gene expression at the genomic level after hormone stimulation. Thus, our findings have enhanced our awareness of the large repertoire of genes and the multiple cell processes and signaling pathways regulated by thyroid hormone. It is likely that such complex regulation of gene expression occurs in other target tissues regulated by thyroid hormone and by other hormones. The use of microarray technology in living animals is a powerful tool to study gene regulation in a physiological system. It will be useful in identifying novel pathways for hormone action and tumorigenesis. It also should prove valuable for drug design as it will enable characterization of agonist and antagonist properties of drugs as well as side effects based upon gene expression patterns.
MATERIALS AND METHODS
Animals
Six-week-old mice were obtained from Charles River Laboratories, Inc. (Wilmington, MA) and maintained in the animal care facility at NIH according to NIH animal care guidelines. Hypothyroid mice were fed a low iodine (loI) diet supplemented with 0.15% PTU purchased from Harlan Teklad Co. (Madison, WI) for 4 weeks (17). After 4 weeks on this diet, hyperthyroid mice were injected ip with 100 mg L-T 3 or T 4 per 100 g mouse body weight in 200 l PBS. Control mice were injected with the same volume of PBS alone. Six hours after thyroid hormone injection, mice were killed by cervical dislocation. Livers were isolated for total RNA isolation. TSH measurements (kindly performed by Dr. Samuel Refetoff, University of Chicago, Chicago, IL) indicated that mice treated with PTU according to this protocol were profoundly hypothyroid before T 3 or T 4 administration (TSH 64-110 ng/ ml, n ϭ 4; nl 0.02-0.95 ng/ml). 
RNA Preparation and Labeling
Total RNA was isolated from mouse livers by RNeasy kit (QIAGEN, Chatsworth, CA) and further purified by TRIZOL reagent (Life Technologies, Inc., Gaithersburg, MD). Total RNA (100 g) was converted to cDNA by using SuperScript II RNA reverse transcriptase (Life Technologies, Inc.) as previously described (10) . RNA isolated from hypothyroid mice was used to prepare cDNA probes labeled with Cy3-deoxyuridine triphosphate (dUTP) dUTP (Amersham Pharmacia Biotech, Piscataway, NJ), and RNA isolated from hyperthyroid mice was used to prepare cDNA labeled with Cy5-dUTP (Amersham Pharmacia Biotech). Labeled cDNA was purified using MicroCon 30 (Amicon, Inc., Beverly, MA).
cDNA Microarray
The cDNA microarrays contained 2,225 elements derived from murine EST clones obtained from Research Genetics, Inc. (Huntsville, AL) as previously described (10) . PCR products generated from these clones were printed onto glass slides as previously described (9, 10) .
Hybridization and Scanning
Labeled cDNA from the hypothyroid mouse and either T 3 -or T 4 -treated mice were hybridized to a 1.0-cm 2 microarray under a 14 ϫ 14 mm glass coverslip overnight at 60 C in a custom-built hybridization chamber, and fluorescence intensities were analyzed by a custom-designed laser confocal microscope as previously described (10, 18) . Image analysis was performed using DEARRAY software (10).
Northern Blotting
Total RNA was prepared from mouse liver using TRIZOL reagent (Life Technologies, Inc.) according to the manufacturer's instructions. Total RNA (20 g) was separated on 1% agarose-formaldehyde gel and then transferred to a nylon transfer membrane (Schleicher & Schuell, Inc., Keene, NH). The blots were probed with gel purified ␣-[ 32 P] dCTP-labeled fragments and exposed to a Biomax film(Eastman Kodak Co., Rochester, NY) at Ϫ70 C. mRNA signals were quantified using ImageQuant software (Molecular Dynamics, Inc., Sunnyvale, CA), and normalized with corresponding thyroid hormone-insensitive 36B4 signals. Fold-inductions were determined from hyperthyroid mice signal values divided by hypothyroid mice signal values within the same experiment.
